OncLive.com· @OncLive · X·· 2 天前评分45
正文 · 原文
🗣️ Kicking things off with Johanna S. Enke, MD of @UCLAHealthJCCC discussing a trial evaluating lutetium Lu 177 vipivotide tetraxetan in prostate cancer.
More overage on our site!
#ESMO26 @myESMO #pcsm #oncology
278 浏览 · 1 赞 · 1 转发 · 0 回复
来源：OncLive.com · x.com